Plasma reduced homocysteine concentrations are increased in end-stage renal disease

Kidney International

Volumn 59, Issue 1, 2001, Pages 372-377

  Hoffer, Leonard John ^a   Robitaille, Line ^a   Elian, Kelly Marie ^a   Bank, Ilana ^a   Hongsprabhas, Pranithi ^a   Mamer, Orval Albert ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Cardiovascular risk factors; Chronic renal disease; Hemodialysis; Hyperhomocysteinemia; Plasma total homocysteine

Indexed keywords

HOMOCYSTEINE;

ADULT; AMINO ACID BLOOD LEVEL; ANALYTIC METHOD; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; GAS CHROMATOGRAPHY; HUMAN; HYPERHOMOCYSTEINEMIA; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; MEASUREMENT; PRIORITY JOURNAL;

EID: 0035172144     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2001.00500.x     Document Type: Article

References (36)

1. Total homocysteine and cardiovascular disease
2. Homocyst(e)ine and cardiovascular disease: A critical review of the epidemiologic evidence
3. Homocysteine and atherothrombosis
4. Homocysteine and vascular disease
5. Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes
6. Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) excess in maintenance dialysis patients: A matched case-control study
7. Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in endstage renal disease and is closely linked to plasma folate and pyridoxine concentrations
8. Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease
9. Homocysteine and arteriosclerosis: Subclinical and clinical disease associations
10. Radioenzymic determination of homocysteine in plasma and urine
11. The detection of cysteine-homocysteine mixed disulphide in plasma of normal fasting man
12. Homocysteine species as components of plasma redox thiol status
13. Biological chemistry of thiols in the vasculature and in vascular-related disease
14. Quantitation of total homocysteine, total cysteine, and methionine in normal serum and urine using capillary gas chromatography-mass spectrometry
15. Total homocysteine in plasma or serum: Methods and clinical applications
16. Plasma total homocyst(e)ine may not be the most appropriate index for cardiovascular disease risk
17. Reduced, oxidized and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status: A possible element of the extracellular antioxidant defense system
18. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection
19. Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma
20. Dynamic relation between reduced, oxidized, and protein-bound homocysteine and other thiol components in plasma during methionine loading in healthy men
21. Homocysteine and other thiols determined in plasma by HPLC and thiol-specific postcolumn derivatization
22. Reduced, free and total fractions of homocysteine and other thiol compounds in plasma from patients with renal failure
23. Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease: Homocysteine and peripheral vascular disease
24. Elevated plasma concentration of reduced homocysteine in patients with human immunodeficiency virus infection
25. Redox status of plasma homocysteine and related aminothiols in smoking and non-smoking young adults
26. Effect of thiol oxidation and thiol export from erythrocytes on determination of redox status of homocysteine and other thiols in plasma from healthy subjects and patients with cerebral infarction
27. Redox status and protein binding of plasma aminothiols during the transient hyperhomocysteinemia that follows homocysteine administration
28. Protein homocysteinylation: Possible mechanism underlying pathological consequences of elevated homocysteine levels
29. Tale of two homocysteines: And two hemodialysis units
30. The concentrations of cysteine and cystine in human blood plasma
31. Plasma cysteine, cystine, and glutathione in cirrhosis
32. Novel reductant for determination of total plasma homocysteine
33. Sulphur containing amino acids in chronic renal failure with particular reference to homocystine and cysteine-homocysteine mixed disulphide
34. The effect of D-penicillamine on protein-bound homocyst(e)ine in homocystinurics
35. Measurement of homocysteine concentrations and stable isotope tracer enrichments in human plasma
36. Homocysteine and vascular disease